Daphne Robert, DPM
Podiatrist · Boston, MANPI 1306138086
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,237 of the $5,007 with a category attached, or 64.7%. 10 manufacturers reported payments, led by Mimedx Group, Inc. at 54.2% of the total.
Across 86 payments — averaging $58.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mimedx Group, Inc.$3K
- Paratek Pharmaceuticals, Inc.$924
- Amgen$447
- Kerecis Limited$250
- Stryker$164
- Averitas Pharma Inc.$151
- plus $356 from 4 others
What the payments were for
- Travel & lodging$1,77035%
- Food & beverage$3,23765%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mimedx Group, Inc. | 9 | $2,714 |
| Paratek Pharmaceuticals, Inc. | 50 | $924 |
| Amgen | 6 | $447 |
| Kerecis Limited | 3 | $250 |
| Stryker | 1 | $164 |
| Averitas Pharma Inc. | 2 | $151 |
| ANI Pharmaceuticals, Inc. | 5 | $133 |
| Organogenesis Inc. | 3 | $102 |
| Smith+Nephew | 3 | $72 |
| Orthofix Medical, Inc. | 4 | $49 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis SurgiClose$536
- KRYSTEXXA$368
- LIMFLOW SYSTEM$164
- Kerecis GraftGuide$134
- Qutenza$121
How this compares
$5,007 in reported general payments places this provider in the 85th percentile of 179 podiatrist providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other podiatrist in Boston
- Thanh DinhBoston$48K
- Barry RosenblumBoston$43K
- Elizabeth SandersBoston$8K
- John GiuriniBoston$6K
- Hau PhamBoston$5K
- Jennifer SkolnikBoston$4K
- Thomas LyonsBoston$2K
- Ashley DanielBoston$2K
- Pasquale CancelliereSomerville$374K
- Michael TheodoulouSomerville$210K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.